Birth weight and its relation with medical nutrition therapy in gestational diabetes

Archives of Gynecology and Obstetrics
Marianne VestgaardFinn Friis Lauszus

Abstract

The cornerstone in treatment of gestational diabetes mellitus (GDM) is medical nutrition therapy (MNT), but the effect on birth weight is disputed. The birth weight was evaluated with respect to length of MNT and adherence to diet. We performed a cohort study on 436 women with GDM and 254 non-diabetic women. Women with a normal oral glucose tolerance test were included as controls as they had similar background predisposition as the women with GDM. The GDM women were subdivided according to MNT and the nutritional status was further stratified according to adherence to the current dietary guidelines. Birth weight above 4 kg was more prevalent in the non-diabetic women compared to the diet-treated GDM women (27 vs. 18%, p = 0.012) but similar to the GDM women who had no MNT (24%). Lower birth weight was associated with longer duration of MNT (r = -0.13, p = 0.021). The birth weight was 1.2 g lower per day of treatment. Medical nutrition therapy was associated with reduction of the fetal weight in women with GDM and the weight decreases with length of treatment. Birth weight above 4 kg was as prominent in the non-diabetic women as in the women with GDM without MNT.

References

Jun 14, 2005·The New England Journal of Medicine·Caroline A CrowtherUNKNOWN Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group
Oct 7, 2006·The American Journal of Clinical Nutrition·Robert G MosesJennie C Brand-Miller
Feb 27, 2008·Diabetes Care·Marshall W Carpenter
Dec 26, 2007·Acta Obstetricia Et Gynecologica Scandinavica·Dorte M JensenPeter Damm
Jul 10, 2009·The Cochrane Database of Systematic Reviews·Nisreen AlwanJane West
Oct 3, 2009·The New England Journal of Medicine·Mark B LandonUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network
Dec 15, 2010·International Journal of Women's Health·Catherine Kim
Feb 24, 2012·Diabetes Care·Patrick M CatalanoUNKNOWN HAPO Study Cooperative Research Group
May 23, 2012·American Journal of Obstetrics and Gynecology·Alison M StuebeUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Bethe
Jul 13, 2012·The Cochrane Database of Systematic Reviews·Shanshan HanCaroline A Crowther
Sep 1, 2012·BMJ : British Medical Journal·Jennifer M WalshFionnuala M McAuliffe
Apr 23, 2013·Nutrition Research·Jimmy Chun Yu LouieJennie C Brand-Miller
Mar 22, 2014·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Ann B RoskjærElisabeth R Mathiesen
Nov 13, 2014·Archives of Gynecology and Obstetrics·Xiu-Jie HeLi Li
Oct 21, 2016·Archives of Gynecology and Obstetrics·Vered KleitmanEyal Sheiner
Feb 27, 2017·The Cochrane Database of Systematic Reviews·Shanshan HanCaroline A Crowther

❮ Previous
Next ❯

Citations

Jul 25, 2018·Current Diabetes Reports·Lili YuenDavid Simmons

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.